Connect with us

Health

UK approves GlaxoSmithKline drug to treat COVID-19

British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it “retains activity” against the new Omicron variant.

For more coronavirus news, visit our dedicated page.

The monoclonal antibody “was found to be safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 infection who are at an increased risk of developing severe disease,” said the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more:

GSK says tests show Vir antibody drug works against Omicron

Moderna exec says company could have Omicron booster ready in March

Fauci: First US case of COVID-19 omicron variant identified

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Pandemic experts express concern over avian influenza spread to humans

The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern, senior UN medics said on Thursday, as they announced new measures to tackle airborne diseases.

Continue Reading

Health

Violations of women’s reproductive health rights trigger rise in preventable deaths

African women are 130 times more likely to die due to pregnancy or childbirth complications than women in Europe and Northern America, the UN sexual and reproductive health agency (UNFPA) said in a new report published on Wednesday.

Continue Reading

Health

Nigeria first country to introduce ‘revolutionary’ meningitis vaccine

Nigeria has become the first country to roll out a “revolutionary” five-in-one vaccine against meningitis, the World Health Organization (WHO) said in a statement on Friday.

Continue Reading

Trending